Literature DB >> 26187220

Primary pulmonary artery sarcoma differentiated from pulmonary thromboembolism by ventilation-perfusion scan. Long survival of the patient.

Beilei Li1, Yiqiu Zhang, Liang Cai, Jun Hou, Hongcheng Shi.   

Abstract

UNLABELLED: Primary pulmonary artery sarcoma (PAS) is a rare and highly lethal tumor. Here, we report a case of a 53-year-old female with PAS who was initially diagnosed with chronic pulmonary thromboembolism (PTE) based on the results of a transthoracic Doppler echocardiogram, a contrast-enhanced computed tomography angiography, and a ventilation/perfusion lung scan.
CONCLUSION: We emphasize the difficulties in diagnosing PAS, the need to investigate this neoplasm in the differential diagnosis of PTE, the diagnostic value of different imaging techniques in the identification of the the tumor, and the efficacy of adjuvant chemotherapy in prolonging survival.

Entities:  

Mesh:

Year:  2015        PMID: 26187220     DOI: 10.1967/s002449910215

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  4 in total

1.  Pulmonary Artery Sarcoma - Multimodality Imaging.

Authors:  Nari Jeong; Sang-Hoon Seol; Il Hwan Kim; Ji Yeon Kim
Journal:  J Clin Imaging Sci       Date:  2016-10-21

2.  When a pulmonary embolism is not a pulmonary embolism: a rare case of primary pulmonary leiomyosarcoma.

Authors:  Nargiz Muganlinskaya; Amanda Guzman; Chanukya Dahagam; Stephen R Selinger
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-12-11

3.  Acute Cardiac Tamponade Secondary to Cardiac Vascular-Type Pleomorphic Leiomyosarcoma: Case Report.

Authors:  Ricardo Fernández-Ferreira; Pamela Denisse Soberanis-Piña; Emilio Conde-Flores; Andrés Mauricio Arroyave-Ramírez; Ileana Mackinney-Novelo; Daniel Motola-Kuba; Jose Manuel Ruiz-Morales; Gabriela Alvarado-Luna; Fredy Chable-Montero
Journal:  Case Rep Oncol       Date:  2021-12-30

4.  Additional treatment prolonged survival of pulmonary artery sarcoma after surgical resection.

Authors:  Liwei Xu; Weishan Lu; Jianqiang Li; Changchun Wang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.